ACT is the transfer of sensitized lymphocytes (such as TILs, CD8+ cells, CD4+ helper cells, and NKs, etc.)which have been manipulated and amplified in vitro to cancer patients to obtain anti-tumor immunity. This evidence concerns the gene CD8A and cancer.